Joined in 2023 
82 
63 About this deal
At Medicalstudyzone.com, we take user experience very seriously and thus always strive to improve. We hope that you people find our blog beneficial! The BNF is jointly published by the Royal Pharmaceutical Society and BMJ. BNF is published in print twice a year and interim updates are issued and published monthly in the digital versions. The following summary provides a brief description of some recent key changes that have been made to BNF content. Updated monographs or dose changes: Benzodiazepines and opioids, Glucagon, Pneumococcal vaccine, SGLT2 inhibitors,
The search functionality through MedicinesComplete makes it easy for health professionals to find drugs, view monographs, and browse related information to support confident decision making. BNF 83 New drug monographs: Estradiol with progesterone (Bijuve), Molnupiravir (Lagerviro), Inclisiran (Leqvio), Vericiguat (Verquvo), Relugolix with estradiol and norethisterone acetate (Ryeqo) MD5 of a better version of this file (if applicable). Fill this in if there is another file that closely matches this file (same edition, same file extension if you can find one), which people should use instead of this file. If you know of a better version of this file outside of Anna’s Archive, then please upload it. BNF 81 New drug monographs: Cefiderocol (Fetcroja), Bempedoic acid (Nilemdo), Solriamfetol (Sunosi)June 2022 Correction of side-effect content in BNF monographs for cetuximab, lenvatinib and regorafenib With the latest update, you now have access to the new features on the BNF app, providing you with an improved experience.
Physicochemical Principles of Pharmacy in Manufacture, Formulation and Clinical Use - 6th ed. (2016)Important safety updates: Amiodarone hydrochloride, COVID-19 antivirals, Chloroquine and hydroxychloroquine sulfate, Haloperidol, Metformin hydrochloride, Pregabalin, Potassium permanganate From June 2023, BNF Publications will be more clearly and consistently identifying specialist drug monographs within content, by including the words “Specialist drug” alongside the monograph title. This feature will be applied to existing monographs, and to monographs moving forward, that are used within specialist settings (such as drugs used for malignancy, and those given via intravitreal injection). These “specialist drug” monographs will contain less detail than a regular monograph within BNF Publications. A “specialist drug” monograph will continue to include information to support patient safety and non-specialist patient care (such as important safety information, interactions, side-effects, and contra-indications), but it will not contain information which is within the remit of specialist care (such as doses, and directions for administration). The valganciclovir drug monograph in BNF for Children has incorrectly included the following equivalence statement since the monograph was added for the July 2018 monthly digital update and the print edition BNF for Children 2018-2019. Completely free for members, our e-Library contains over 100 essential pharmacy e-Book texts curated by our professionallibrarian, as well as:
The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by healthcare professionals across the world to support confident decision-making at the point of care. Blood Results in Clinical Practice: A Practical Guide to Interpreting Blood Test Results - 2nd ed. (2019) Ibrutinib (Imbruvica®): new risk minimisation measures, including dose modification recommendations, due to the increased risk for serious cardiac events Pharmaceutical Preformulation and Formulation: a Practical Guide from Candidate Drug Selection to Commercial Dosage Form - 2nd ed. (2009) Ideal for use by Pharmacists, Chemists, Nurses and Doctors within Hospitals, Nursing Homes, Pharmacies and Hospices and the ideal reference tool for all Care and support staff. See also:
An integral part of the UK’s healthcare infrastructure and relied on by health professionals who prescribe, dispense, and administer medicines globally. Containing guidance on best practice in prescribing, as well as legal and ethical considerations, BNF supports safe and effective decision-making at the point of care. Pre-treatment screening advice on genetic testing for aminoglycoside exposure posing risk to hearing
Great Deal 
New Comment